Secondary Anticoagulation Use in Patients < 21 Years Old following Primary Anticoagulant Treatment for Provoked Venous Thromboembolism: Findings from the Kids-DOTT TrialSEMINARS IN THROMBOSIS AND HEMOSTASISIF4.12024-09-191PRE
Evaluation of Venous Thromboembolism Risk Factors Reveals Subtype Heterogenicity in Children with Central Venous Catheters: A Multi-Center Study from the CHAT Consortium (vol 21, pg 2441, 2023)JOURNAL OF THROMBOSIS AND HAEMOSTASISIF52023-12-010PRE
Evaluation of venous thromboembolism risk factors reveals subtype heterogenicity in children with central venous catheters: a multicenter study from the Children's Hospital Acquired Thrombosis consortiumJOURNAL OF THROMBOSIS AND HAEMOSTASISIF52023-09-013OAAI
Risk of venous thromboembolism in pediatric hospitalized patients undergoing noncardiac surgery: A report from the Children's Hospital-Acquired Thrombosis consortium接受非心脏手术的儿科住院患者的静脉血栓栓塞风险: 来自儿童医院获得性血栓形成协会的报告RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASISIF3.42022-10-010OAAI
Symptomatic pulmonary embolus after catheter removal in children with catheter related thrombosis: A report from the CHAT ConsortiumJOURNAL OF THROMBOSIS AND HAEMOSTASISIF52022-01-019OAAI
The effect of age at diagnosis of type 1 von Willebrand disease on diagnostic laboratory values: A paediatric perspectiveHAEMOPHILIAIF32021-02-031PREAI
Development of a Risk Model for Pediatric Hospital-Acquired Thrombosis: A Report from the Children's Hospital-Acquired Thrombosis ConsortiumJOURNAL OF PEDIATRICSIF3.52021-01-0123OAAI
The RFX family interacts at the collagen (COL1A2) start site and represses transcriptionJOURNAL OF BIOLOGICAL CHEMISTRYIF3.92002-07-0158OAAI